Incannex Healthcare Inc ADR (IXHL)

$0.41 +0.01 (1.73%)
Market Cap 139.74M
Revenue (ttm) 90,000.00
Net Income (ttm) -46.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -52,100.00%
Debt to Equity Ratio 0.00
Volume 2,759,700
Avg Vol 22,207,100
Day's Range N/A - N/A
Shares Out 346.23M
Stochastic %K 41%
Beta 7.46
Analysts Hold
Price Target N/A

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety diso...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 61 4 0984 0786
Address:
8 Century Circuit, Suite 105 Norwest, Sydney, Australia
Ond_Stock_Mind
Ond_Stock_Mind Dec. 25 at 2:22 PM
$IXHL
0 · Reply
Imhereforthapartay
Imhereforthapartay Dec. 25 at 1:59 PM
$IXHL
0 · Reply
Jack_Mehoff42069
Jack_Mehoff42069 Dec. 25 at 1:46 PM
$IXHL had a dream last night that I opened Robinhood and $IXHL had made me . Lol anyway Merry Christmas everyone, I hope all have a very blessed day.
1 · Reply
Jack_Mehoff42069
Jack_Mehoff42069 Dec. 25 at 1:40 PM
$IXHL Correct me if wrong but does that not say that it expired in 2024 on May 31st?
1 · Reply
Tradeq10
Tradeq10 Dec. 25 at 1:15 PM
$IXHL someone reach out to him to partner with ixhl 😂😂
0 · Reply
bound4glory
bound4glory Dec. 25 at 1:06 PM
$IXHL Sorry but I will post the true meaning of Christmas on Christmas day. Just take it with a grain of salt if it's not your cup of tea.
2 · Reply
YJHGJII
YJHGJII Dec. 25 at 1:02 PM
$VELO $OCG $HYMC $IXHL
0 · Reply
Rvvrn9
Rvvrn9 Dec. 25 at 12:58 PM
$IXHL Exactly!!! Read the incentives, not the emotions. Management isn’t paid for reverse splits or dragging this out, they’re paid for transactions. These grants trigger on acquisitions, JV, licensing, or asset sales… not desperately trying to survive. Caretakers get RS incentives. Dealmakers get acquisition incentives.💪 Draw your own conclusions. GLTA
1 · Reply
User4004
User4004 Dec. 25 at 12:22 PM
$IXHL sorry but if we can’t talk about politics here , we shouldn’t be shoving prayers and scripture down peoples throat. Not all of us share the same beliefs.
0 · Reply
User4004
User4004 Dec. 25 at 12:08 PM
$IXHL some hillbilly in Arkansas won 1.8B power ball last night
1 · Reply
Latest News on IXHL
Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

Dec 3, 2025, 8:00 AM EST - 22 days ago

Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026

Nov 20, 2025, 9:34 AM EST - 5 weeks ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus

Oct 30, 2025, 8:00 AM EDT - 2 months ago

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus

Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Oct 22, 2025, 8:00 AM EDT - 2 months ago

Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Aug 26, 2025, 8:00 AM EDT - 4 months ago

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Aug 22, 2025, 8:00 AM EDT - 4 months ago

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Aug 19, 2025, 4:29 PM EDT - 4 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Aug 8, 2025, 8:00 AM EDT - 4 months ago

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Jul 31, 2025, 8:00 AM EDT - 5 months ago

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial

Jul 30, 2025, 10:10 AM EDT - 5 months ago

Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Jul 30, 2025, 8:00 AM EDT - 5 months ago

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Jul 25, 2025, 7:30 AM EDT - 5 months ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Jun 24, 2025, 7:30 AM EDT - 6 months ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Jun 18, 2025, 7:30 AM EDT - 6 months ago

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Jun 17, 2025, 7:30 AM EDT - 6 months ago

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jun 12, 2025, 7:30 AM EDT - 7 months ago

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Jun 3, 2025, 7:30 AM EDT - 7 months ago

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

May 29, 2025, 7:30 AM EDT - 7 months ago

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

May 28, 2025, 4:21 PM EDT - 7 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

May 28, 2025, 7:00 AM EDT - 7 months ago

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

May 20, 2025, 7:30 AM EDT - 7 months ago

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

May 16, 2025, 9:00 AM EDT - 7 months ago

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

May 15, 2025, 8:00 AM EDT - 8 months ago

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

May 14, 2025, 4:14 PM EDT - 8 months ago

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

May 14, 2025, 8:00 AM EDT - 8 months ago

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Apr 3, 2025, 7:30 AM EDT - 9 months ago

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Mar 7, 2025, 2:10 PM EST - 10 months ago

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Feb 18, 2025, 5:51 PM EST - 11 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Feb 14, 2025, 7:30 AM EST - 11 months ago

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Feb 4, 2025, 9:15 AM EST - 11 months ago

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Jan 23, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Dec 2, 2024, 4:48 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Nov 14, 2024, 4:05 PM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Oct 24, 2024, 7:30 AM EDT - 1 year ago

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Oct 2, 2024, 4:50 PM EDT - 1 year ago

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sep 30, 2024, 4:01 PM EDT - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Aug 5, 2024, 7:30 AM EDT - 1 year ago

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Jul 30, 2024, 7:30 AM EDT - 1 year ago

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

May 30, 2024, 7:30 AM EDT - 1 year ago

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

May 7, 2024, 7:30 AM EDT - 1 year ago

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

May 1, 2024, 2:33 PM EDT - 1 year ago

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Feb 16, 2024, 7:30 AM EST - 2 years ago

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Clarion Clinics Open for Psychedelic-Assisted Treatments

Feb 1, 2024, 7:30 AM EST - 2 years ago

Clarion Clinics Open for Psychedelic-Assisted Treatments

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Jan 24, 2024, 4:05 PM EST - 2 years ago

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Jan 18, 2024, 8:22 AM EST - 2 years ago

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Jan 17, 2024, 7:30 AM EST - 2 years ago

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Dec 21, 2023, 4:05 PM EST - 2 years ago

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Dec 6, 2023, 7:30 AM EST - 2 years ago

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

Nov 29, 2023, 1:40 PM EST - 2 years ago

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

Ond_Stock_Mind
Ond_Stock_Mind Dec. 25 at 2:22 PM
$IXHL
0 · Reply
Imhereforthapartay
Imhereforthapartay Dec. 25 at 1:59 PM
$IXHL
0 · Reply
Jack_Mehoff42069
Jack_Mehoff42069 Dec. 25 at 1:46 PM
$IXHL had a dream last night that I opened Robinhood and $IXHL had made me . Lol anyway Merry Christmas everyone, I hope all have a very blessed day.
1 · Reply
Jack_Mehoff42069
Jack_Mehoff42069 Dec. 25 at 1:40 PM
$IXHL Correct me if wrong but does that not say that it expired in 2024 on May 31st?
1 · Reply
Tradeq10
Tradeq10 Dec. 25 at 1:15 PM
$IXHL someone reach out to him to partner with ixhl 😂😂
0 · Reply
bound4glory
bound4glory Dec. 25 at 1:06 PM
$IXHL Sorry but I will post the true meaning of Christmas on Christmas day. Just take it with a grain of salt if it's not your cup of tea.
2 · Reply
YJHGJII
YJHGJII Dec. 25 at 1:02 PM
$VELO $OCG $HYMC $IXHL
0 · Reply
Rvvrn9
Rvvrn9 Dec. 25 at 12:58 PM
$IXHL Exactly!!! Read the incentives, not the emotions. Management isn’t paid for reverse splits or dragging this out, they’re paid for transactions. These grants trigger on acquisitions, JV, licensing, or asset sales… not desperately trying to survive. Caretakers get RS incentives. Dealmakers get acquisition incentives.💪 Draw your own conclusions. GLTA
1 · Reply
User4004
User4004 Dec. 25 at 12:22 PM
$IXHL sorry but if we can’t talk about politics here , we shouldn’t be shoving prayers and scripture down peoples throat. Not all of us share the same beliefs.
0 · Reply
User4004
User4004 Dec. 25 at 12:08 PM
$IXHL some hillbilly in Arkansas won 1.8B power ball last night
1 · Reply
bound4glory
bound4glory Dec. 25 at 9:37 AM
$IXHL May we remember that Christmas was when God left heaven to provide a way for His creation to come to heaven. A free gift that only needs to be open. Merry Christmas and good tidings to all. ✝️
0 · Reply
JackB2025
JackB2025 Dec. 25 at 9:29 AM
$IXHL Exactly my thinking mate and I always refer back to his acquisition incentives. 🙏🏻🙏🏻
3 · Reply
DLH2
DLH2 Dec. 25 at 8:49 AM
$IXHL guys instead of the billion dollar valuations has anyone actually thought of the phase 3 doesn’t go as they expect this could easily drop of a cliff again
1 · Reply
SteadyHawk
SteadyHawk Dec. 25 at 7:32 AM
$IXHL Only 600,000 shares were shorted yesterday, the lowest I've seen since May. If this stock is so bad why isn't it being shorted and crushed? Why is the amount of shorts only going down instead of up? All the funded bears here are probably being run by hedge funds whose job is to discourage retailers from releasing more shares so they can buy without raising the price, that's the truth.
2 · Reply
PovertyProfessor
PovertyProfessor Dec. 25 at 6:14 AM
$IXHL Joseph Swan(CFO) aka Joe Swanson
0 · Reply
nmzl
nmzl Dec. 25 at 5:47 AM
$IXHL Their 2023 equity grants have tanked in value and they haven't sold a single share. They certainly don't want the same outcome again. As an exec, I definitely don't want to be underpaid for years unless I am Elon! So, yes - a deal is being negotiated. NFA
0 · Reply
nmzl
nmzl Dec. 25 at 5:33 AM
$IXHL Buyout deal is being negotiated by Joel with Bob Clark's guidance. Bob wants a great 2026 and doesn't want to be stuck holding penny shares waiting for value to catch up ! Merry Christmas 🎄🎁 NFA.
1 · Reply
For1Retailer
For1Retailer Dec. 25 at 5:23 AM
$IXHL Merry Christmas 🎄
0 · Reply
lousjamsession
lousjamsession Dec. 25 at 5:15 AM
$IXHL ....
0 · Reply
Bigsky007
Bigsky007 Dec. 25 at 5:02 AM
$IXHL We’re all just a bunch of lost souls trying to get by…
0 · Reply
maximus_d_meridius
maximus_d_meridius Dec. 25 at 4:57 AM
$IXHL https://youtu.be/kR2IihSs2QE?si=DQt3mEjcCCoV9VtF Merry Christmas to all!!!
0 · Reply
malibu_rum67
malibu_rum67 Dec. 25 at 4:55 AM
$IXHL … Merry Christmas To All My Constituents And Those I Considered Friends In This Journey!!! We Shall See This Through And Will At One Point Changed Lives😊!!!
0 · Reply